Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI (-COMPLETE-NSTEMI-)

NCT05786131 is registered in ClinicalTrials.gov with Leipzig Heart Science gGmbH as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05786131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI (-COMPLETE-NSTEMI-)
Lead sponsor
Leipzig Heart Science gGmbH
Phase
Not applicable
Overall status
Recruiting
Start date
October 27, 2023
Completion date
July 31, 2027
Enrollment
3,390 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

multivessel coronary artery disease, non-st-elevation myocardial infarction